Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LYKA LABS Fact Sheet  (LYLB)



Revealed: A Potential Huge Investing Opportunity for Investors


Here is the latest financial fact sheet of LYKA LABS. For more details, see the LYKA LABS quarterly results and LYKA LABS share price. For a sector overview, read our pharmaceuticals sector report.

LYKA LABS Price History

Price Rs 120.7
Mkt Cap Rs m 3,992
Vol '000 8.5
P/E X -113.2
P/CF X 401.3
EPS (TTM) Rs -1.1
1 Day % -3.2
No. of shares m 33.09
1 Week % -5.5
1 Month % 7.3
1 Year % 17.0
52 week H/L Rs 143.5/89.0
As on Apr 30, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LYKA LABS Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
LYKA LABS EQUITY SHARE DATA
High Rs523536267202 
Low Rs21101325100 
Sales per share (Unadj.) Rs25.221.430.167.630.3 
Earnings per share (Unadj.) Rs-2.3-21.8-3.513.4-4.3 
Diluted earnings per shareRs-1.9-18.9-3.011.6-4.0 
Cash flow per share (Unadj.) Rs0.3-19.0-0.619.40.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs15.0-5.0-9.04.69.1 
Adj. book value per shareRs12.8-4.3-7.84.08.5 
Shares outstanding (eoy) m28.1428.6928.6928.6930.69 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.51.00.82.25.0 
Avg P/E ratio x-16.3-1.0-6.910.9-35.2 
P/CF ratio (eoy) x107.4-1.2-39.37.5465.7 
Price / Book Value ratio x2.4-4.5-2.731.416.5 
Dividend payout %00000 
Avg Mkt Cap Rs m1,0336456944,1894,634 
No. of employees `000NANANANANA 
Total wages/salary Rs m147139146181186 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
LYKA LABS INCOME DATA
Net Sales Rs m7086158631,941931 
Other income Rs m2131162134 
Total revenues Rs m7296468781,962965 
Gross profit Rs m-30-36918694694 
Depreciation Rs m738083173141 
Interest Rs m72201259201119 
Profit before tax Rs m-154-619-141592-132 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-917-412080 
Profit after tax Rs m-64-626-101384-132 
Gross profit margin %-4.3-60.021.548.810.1 
Effective tax rate %58.8-1.228.735.10.1 
Net profit margin %-9.0-101.8-11.719.8-14.1 
LYKA LABS BALANCE SHEET DATA
Current assets Rs m351359291522442 
Current liabilities Rs m848663499994326 
Net working cap to sales %-70.2-49.5-24.1-24.312.5 
Current ratio x0.40.50.60.51.4 
Inventory Days Days149116874190 
Debtors Days Days754477367347789 
Net fixed assets Rs m1,6771,5201,4461,3341,073 
Share capital Rs m281287287287307 
"Free" reserves Rs m141-430-545-154-27 
Net worth Rs m423-143-258133280 
Long term debt Rs m7931,2611,514625638 
Total assets Rs m2,0291,8791,7371,8561,515 
Interest coverage x-1.2-2.10.53.9-0.1 
Debt to equity ratio x1.9-8.8-5.94.72.3 
Sales to assets ratio x0.30.30.51.00.6 
Return on assets %0.4-22.69.131.6-0.8 
Return on equity %-15.0436.539.1288.2-47.0 
Return on capital %-6.8-37.49.4104.7-1.4 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
LYKA LABS CASH FLOW
From Operations Rs m 267 53 88 792 90 
From Investments Rs m -40 -1 -2 -62 74 
From Financial Activity Rs m -234 34 -118 -632 -216 
Net Cashflow Rs m -7 86 -31 99 -53 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 54.8%
Institution 1.0%
Non-Institution 44.2%
Total 100.0%
Free Float 45.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 4801/B & 4802/A, G I D C Industrial Estate, Ankleshwar - 393002
E-mail companysecretary@lykalabs.com Web www.lykalabs.com
Tel 02646221422 /220549 Fax 02646-250692
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, L B S Marg, Vikhroli (West)
Auditor C. C. Chokshi & Co.
CHM: Babulal Jain COMP SEC: Kishore P Shah YEAR OF INC: 1976 BSE CODE: 500259 FV (Rs): 10 DIV YIELD (%): -

Read: LYKA LABS 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare LYKA LABS With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.